Every time a stem cell divides, one daughter cell remains a stem cell while the other takes off on its own developmental journey.
‘Excited to be back’: Roche’s sequel to failed Alzheimer’s antibody looks promising in early study
A year ago, Roche’s future in Alzheimer’s disease looked uncertain. At an Alzheimer’s conference in San Francisco, the pharmaceutical company announced that its amyloid-targeting antibody